2,174
Views
13
CrossRef citations to date
0
Altmetric
RESEARCH PAPER

Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production

, , , , , , , , , , , & show all
Pages 490-506 | Received 14 Sep 2015, Accepted 30 Nov 2015, Published online: 18 Feb 2016

Reference

  • Choi J, Chen J, Schreiber SL, Clardy J. Structure of the FKBP1 2-Rapamycin complex interacting with the binding domain of human FRAP. Science 1996; 273:239-41; PMID:8662507; http://dx.doi.org/10.1126/science.273.5272.239
  • Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT. Isolation of a protein taeget of the FKBP12-Rapamycin complex in mammalian cells. J Biol Chem 1995; 270(2):815-22; PMID:7822316; http://dx.doi.org/10.1074/jbc.270.2.815
  • Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Science 1994; 369:756-8.
  • Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL, Kockel L. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010; 11(6):453-65; PMID:20519118; http://dx.doi.org/10.1016/j.cmet.2010.05.001
  • Andre C, Cota D. Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway. Proc Nutr Soc 2012; 71(4):502-10; PMID:22877732; http://dx.doi.org/10.1017/S0029665112000754
  • Lee C, Longo VD. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene 2011; 30(30):3305-16; PMID:21516129; http://dx.doi.org/10.1038/onc.2011.91
  • Jewell JL, Guan KL. Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 2013; 38(5):233-42; PMID:23465396; http://dx.doi.org/10.1016/j.tibs.2013.01.004
  • Kim SG, Buel GR, Blenis J. Nutrient regulation of the mTOR complex 1 signaling pathway. Mol Cells 2013; 35(6):463-73; PMID:23694989; http://dx.doi.org/10.1007/s10059-013-0138-2
  • Efeyan A, Zoncu R, Sabatini DM. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med 2012; 18(9):524-33; PMID:22749019; http://dx.doi.org/10.1016/j.molmed.2012.05.007
  • Jewell JL, Russell RC, Guan KL. Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 2013; 14(3):133-9; PMID:23361334; http://dx.doi.org/10.1038/nrm3522
  • Anderson RM, Shanmuganayagam D, Weindruch R. Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol 2009; 37(1):47-51; PMID:19075044; http://dx.doi.org/10.1177/0192623308329476
  • Colman RJ, Beasley TM, Kemnitz JW, Johnson SC, Weindruch R, Anderson RM. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun 2014; 5:3557; PMID:24691430; http://dx.doi.org/10.1038/ncomms4557
  • Weindruch R, et al. Symposium: calorie restriction: effects on body composition, insulin signaling and aging. J Nutr 2001; 131(3):918s-923s; PMID:11238786
  • Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005; 17(6):596-603; PMID:16226444; http://dx.doi.org/10.1016/j.ceb.2005.09.009
  • Laplante M, Sabatini DM. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 2013; 126(Pt 8):1713-9; PMID:23641065; http://dx.doi.org/10.1242/jcs.125773
  • Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14(14):1296-302; PMID:15268862; http://dx.doi.org/10.1016/j.cub.2004.06.054
  • Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006; 22(2):159-68; PMID:16603397; http://dx.doi.org/10.1016/j.molcel.2006.03.029
  • Bjedov I, Partridge L. A longer and healthier life with TOR downregulation: genetics and drugs. Biochem Soc Trans 2011; 39(2):460-5; PMID:21428920; http://dx.doi.org/10.1042/BST0390460
  • Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, Partridge L. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab 2010; 11(1):35-46; PMID:20074526; http://dx.doi.org/10.1016/j.cmet.2009.11.010
  • Zhang Y, Bokov A, Gelfond J, Soto V, Ikeno Y, Hubbard G, Diaz V, Sloane L, Maslin K, Treaster S, et al. Rapamycin extends life and health in C57BL/6 mice. J Gerontol A Biol Sci Med Sci 2014; 69(2):119-30; PMID:23682161; http://dx.doi.org/10.1093/gerona/glt056
  • Neff F, Flores-Dominguez D, Ryan DP, Horsch M, Schröder S, Adler T, Afonso LC, Aguilar-Pimentel JA, Becker L, Garrett L, et al. Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest 2013; 123(8):3272-91; PMID:23863708; http://dx.doi.org/10.1172/JCI67674
  • Robida-Stubbs S, Glover-Cutter K, Lamming DW, Mizunuma M, Narasimhan SD, Neumann-Haefelin E, Sabatini DM, Blackwell TK. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab 2012; 15(5):713-24; PMID:22560223; http://dx.doi.org/10.1016/j.cmet.2012.04.007
  • Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460(7253):392-5; PMID:19587680
  • Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8(12):1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606
  • Xu Y, Li N, Xiang R, Sun P. Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci 2014; 39(6):268-76; PMID:24818748; http://dx.doi.org/10.1016/j.tibs.2014.04.004
  • Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 2011; 3(89):89ra58; http://dx.doi.org/10.1126/scitranslmed.3002346
  • Carter D, Chakalova L, Osborne CS, Dai YF, Fraser P. Long-range chromatin regulatory interactions in vivo. Nat Genet 2002; 32(4):623-6; PMID:12426570; http://dx.doi.org/10.1038/ng1051
  • Tolhuis B, Blom M, Kerkhoven RM, Pagie L, Teunissen H, Nieuwland M, Simonis M, de Laat W, van Lohuizen M, van Steensel B. Interactions among Polycomb domains are guided by chromosome architecture. PLoS Genet 2011; 7(3):e1001343; PMID:21455484; http://dx.doi.org/10.1371/journal.pgen.1001343
  • Schoenfelder S, Sexton T, Chakalova L, Cope NF, Horton A, Andrews S, Kurukuti S, Mitchell JA, Umlauf D, Dimitrova DS, et al. Preferential associations between co-regulated genes reveal a transcriptional interactome in erythroid cells. Nat Genet 2010; 42(1):53-61; PMID:20010836; http://dx.doi.org/10.1038/ng.496
  • Mehta IS, Amira M, Harvey AJ, Bridger JM. Rapid chromosome territory relocation by nuclear motor activity in response to serum removal in primary human fibroblasts. Genome Biol 2010; 11(1):R5; PMID:20070886; http://dx.doi.org/10.1186/gb-2010-11-1-r5
  • Mehta IS, Eskiw CH, Arican HD, Kill IR, Bridger JM. Farnesyltransferase inhibitor treatment restores chromosome territory positions and active chromosome dynamics in Hutchinson-Gilford progeria syndrome cells. Genome Biol 2011; 12(8):R74; PMID:21838864; http://dx.doi.org/10.1186/gb-2011-12-8-r74
  • Bridger JM, Kill IR, O'Farrell M, Hutchison CJ. Internal lamin structures within G1 nuclei of human dermal fibroblasts. J Cell Sci 1993; 104:297-306; PMID:8505362
  • Bridger JM, Kill IR, Lichter P. Association of pKi-67 with satellite DNA of the human genome in early G1 cells. Chromosome Res 1998; 6:13-24; PMID:9510506; http://dx.doi.org/10.1023/A:1009210206855
  • Booth DG, Takagi M, Sanchez-Pulido L, Petfalski E, Vargiu G, Samejima K, Imamoto N, Ponting CP, Tollervey D, Earnshaw WC, et al. Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery. Elife 2014; 3:e01641; PMID:24867636
  • Ladoire S, Chaba K, Martins I, Sukkurwala AQ, Adjemian S, Michaud M, Poirier-Colame V, Andreiuolo F, Galluzzi L, White E, et al. Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy 2012; 8(8):1175-84; PMID:22647537; http://dx.doi.org/10.4161/auto.20353
  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res 2003; 13(1):2498-504; PMID:14597658; http://dx.doi.org/10.1101/gr.1239303
  • Wu G, Feng X, Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol 2010; 11(5):R53; PMID:20482850; http://dx.doi.org/10.1186/gb-2010-11-5-r53
  • Frith MC, Fu Y, Yu L, Chen JF, Hansen U, Weng Z. Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res 2004; 32(4):1372-81; PMID:14988425; http://dx.doi.org/10.1093/nar/gkh299
  • Salas EM, García-Barchino MJ, Labiano S, Shugay M, Pérez-Encinas M, Quinteiro C, García-Delgado M, Vizmanos JL, Novo FJ. LIF, a Novel STAT5-Regulated Gene, Is Aberrantly Expressed in Myeloproliferative Neoplasms. Genes Cancer 2011; 2(5):593-6; PMID:21901172; http://dx.doi.org/10.1177/1947601911420139
  • Takahashi R, Yoshimura A. SOCS1 and regulation of regulatory T cells plasticity. J Immunol Res 2014; 2014:943149; PMID:25133199; http://dx.doi.org/10.1155/2014/943149
  • Peltola KJ, Paukku K, Aho TL, Ruuska M, Silvennoinen O, Koskinen PJ. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood 2004; 103(10); PMID:14764533; http://dx.doi.org/10.1182/blood-2003-09-3126
  • Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15:707-747; http://dx.doi.org/10.1146/annurev.immunol.15.1.707
  • Zheng J, Fang F, Zeng X, Medler TR, Fiorillo AA, Clevenger CV. Negative cross talk between NFAT1 and Stat5 signaling in breast cancer. Mol Endocrinol 2011; 25(12):2054-64; PMID:21964595; http://dx.doi.org/10.1210/me.2011-1141
  • Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS Biol 2006; 4(3):e83; PMID:16509772; http://dx.doi.org/10.1371/journal.pbio.0040083
  • Lee WM, Paik JS, Cho WK, Oh EH, Lee SB, Yang SW. Rapamycin enhances TNF-α-induced secretion of IL-6 and IL-8 through suppressing PDCD4 degradation in orbital fibroblasts. Curr Eye Res 2013; 38(6):699-706; PMID:23281820; http://dx.doi.org/10.3109/02713683.2012.750368
  • Zhao J, Benakanakere MR, Hosur KB, Galicia JC, Martin M, Kinane DF. Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes. Mol Immunol 2010; 48(1-3):294-304; PMID:20728939; http://dx.doi.org/10.1016/j.molimm.2010.07.014
  • Domhan S, Schwager C, Wei Q, Muschal S, Sommerer C, Morath C, Wick W, Maercker C, Debus J, Zeier M, et al. Deciphering the systems biology of mTOR inhibition by integrative transcriptome analysis. Curr Pharm Des 2014; 20(1):88-100; PMID:23530502; http://dx.doi.org/10.2174/138161282001140113125549
  • Kojima H, Inoue T, Kunimoto H, Nakajima K. IL-6-STAT3 signaling and premature senescence. JAKSTAT 2013; 2(4):e25763; PMID:24416650
  • Garbers C, Kuck F, Aparicio-Siegmund S, Konzak K, Kessenbrock M, Sommerfeld A, Häussinger D, Lang PA, Brenner D, Mak TW, et al. Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR). Cell Cycle 2013; 12(21):3421-32; PMID:24047696; http://dx.doi.org/10.4161/cc.26431
  • Laberge RM, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L, Curran SC, Davalos AR, Wilson-Edell KA, Liu S, et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 2015; 17(8):1049-61; PMID:26147250
  • Galic S, Sachithanandan N, Kay TW, Steinberg GR. Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. Biochem J 2014; 461(2):177-88; PMID:24966052; http://dx.doi.org/10.1042/BJ20140143
  • Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008; 224(1):265-83; PMID:18759933; http://dx.doi.org/10.1111/j.1600-065X.2008.00659.x
  • Krebs DL, Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 2000(113):2813-9; PMID:10910765
  • Saleiro D, Platanias LC. Intersection of mTOR and STAT signaling in immunity. Trends Immunol 2015; 36(1):21-9; PMID:25592035; http://dx.doi.org/10.1016/j.it.2014.10.006
  • Croft JA, Bridger JM, Boyle S, Perry P, Teague P, Bickmore WA. Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol 1999; 145(6):1119-1131; PMID:10366586; http://dx.doi.org/10.1083/jcb.145.6.1119
  • Vincent L, Soille P. Watersheds in digital spaces: an efficient algorithm based on immersion simulations. IEEE Transactions on Pattern Analysis and Machine Intelligence 1991; 13(6):583-98; http://dx.doi.org/10.1109/34.87344
  • Mitchell JA, Clay I, Umlauf D, Chen CY, Moir CA, Eskiw CH, Schoenfelder S, Chakalova L, Nagano T, Fraser P. Nuclear RNA sequencing of the mouse erythroid cell transcriptome. PLoS One 2012; 7(11):e49274; PMID:23209567; http://dx.doi.org/10.1371/journal.pone.0049274
  • Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, Tirado F, Carazo JM, Pascual-Montano A. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 2009; 37(Web Server issue):W317-22; PMID:19465387; http://dx.doi.org/10.1093/nar/gkp416
  • Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 2012; 40(Web Server issue):W478-83; PMID:22573175; http://dx.doi.org/10.1093/nar/gks402

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.